These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures. Certain uses of devices included in these publications may not have been IVD-approved or cleared by regulatory bodies.
Actionable Changes and Outcomes from Rapid Phenotypic Antimicrobial Susceptibility Testing in Hospitalized Patients with Bloodstream Infection - IMARI 2026 (external collaborator)
2026
Poster
Evaluation of KWIK-STIK™ for Streamlined Quality Control on the ASTar® System - IMARI 2026
2026
Poster
Evaluation of ASTar® remnant bacterial suspension for lateral flow immunoassay detection and differentiation of resistance mechanisms in Gram-negative resistant contrived blood cultures - IMARI 2026
2026
Poster
A Pooled Performance and Adjudication Analysis of ASTar® Rapid Antimicrobial Susceptibility Testing System from Gram-negative Positive Blood Cultures (Updated) - IMARI 2026
2026
Poster
Savings in Sepsis: The Implementation and Impact of the Q-linea ASTar System withinMersey and West Lancashire NHS Teaching Hospitals Trust - IBMS 2025
2025
Poster
Performance Evaluation of the ASTar System for Rapid Antimicrobial Susceptibility Testing from Positive Blood Cultures - TYKS
2025
Poster
Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures: A Pilot Study on the ASTar System - Quest - ASM 2025
2025
Poster
Performance of a System for Direct Rapid Antimicrobial Susceptibility from Blood Culture - PSU - ASM 2025
2025
Poster
Evaluation of the ASTar® system for Rapid Susceptibility Testing Directly from Positive Blood Cultures from Oncology Patients with Bloodstream Infections - MSKCC - ASM 2025
2025
Poster
Evaluation of a Rapid Antimicrobial Susceptibility Testing System from Positive Blood Cultures for Accuracy and Potential Clinical Impact - GWU - ASM 2025
2025
Poster
Advancing Antimicrobial Therapy Evaluating the ASTar Q-linea System for Rapid AST in Gram-Negative Bloodstream Infections - BSW - ASM 2025
2025
Poster
Rapid AST enables treatment optimization over 1.3 days faster for BSI patients The LIFETIMES study - ASM 2025
2025
Poster
Controlled inoculum functionality of an automated rapid AST system leads to consistent MIC determination - ASM 2025
2025
Poster
Potential impact of rapid phenotypic antimicrobial susceptibility testing on antimicrobial therapy in patients with Gram-negative bloodstream infections - MAD-ID 2025
2025
Poster
Rapid AST enables treatment optimisation over 32 h earlier than standard of care for BSI patients: interim results of the LIFETIMES study - ESCMID Global 2025
2025
Poster
Rapid phenotypic susceptibility testing from patient blood cultures with growth of Streptococci or other Gram-positive bacteria - ESCMID Global 2025
2025
Poster
Controlled inoculum functionality of an automated rapid AST system leads to consistent MIC determination - ESCMID Global 2025
2025
Poster
Evaluation and potential clinical impact of a rapid AST method direct from Gram-negative blood cultures - SWACM 2024
2024
Poster
Rapid AST results for gram-negative bacteremia and the time to effective and optimal antimicrobial therapy, J. Boelens et al., Ghent University Hospital. - ESICM 2024.
2024
Poster
Performance evaluation of Meropenem-Vaborbactam on clinical isolates in a fully automated rapid AST system - ESCMID Global 2024.
2024
White Paper
The Health and Economic Impact of Rapid AST in the Management of Bloodstream Infections
2024
Brochure
ASTar - Designed to save lifetimes
2024
Application Note
Advantages of the ASTar System
2024
Poster
The LIFETIMES Study – Interim Results from a Health and Economic Evaluation of a Rapid Phenotypic AST System - ASM Microbe 2024
2024
Poster
Rapid AST expedites antimicrobial therapy optimisation in BSI patients – clinical cases from the LIFETIMES HEOR study - ESCMID Global 2024
2024
Poster
Interim results of a clinical and economic evaluation of a rapid AST system – the LIFETIMES study - ESCMID Global 2024
2024
Poster
A new assay for rapid antimicrobial susceptibility testing of bloodstream infection-causing gram-negative bacteria - ASM 2023
2023
Poster
Performance Evaluation for Piperacillin/Tazobactam in ESBL-Producing E. coli Strains (OXA-1 and TEM-1) in an Automated Rapid AST System Using the New FDA Breakpoints - ASM 2023
2023
Poster
Fully Automated Phenotypic Resistance Reporting in 3 Hours, Directly from a Positive Blood Culture - ECCMID 2021
2021
Application Note
A workflow for early and accurate treatment of sepsis
2020
Poster
Accurate inoculum preparation for AST from various samples - ASM 2019
2019
Poster
Rapid phenotypic AST direct from different clinical specimens as well as isolates on the same automated system - ECCMID 2019
2019
Poster
Automated inoculum preparation for AST from crude samples - ECCMID 2019
2019
Poster
Antimicrobial Susceptibility Test System Delivering Phenotypic MICs in Hours from Positive Blood Cultures for Fastidious- and Non-Fastidious Pathogens - ASM 2018
2018
Poster
Opportunity for very rapid phenotypic susceptibility testing of clinical specimens using the novel ASTar platform - ASM 2018
2018
Poster
MALDI-TOF MS Identification and Phenotypic AST Delivering True MICs in Hours, Directly from Clinical Positive Blood Cultures - ASM 2018
2018
Poster
Poster - Mass spectrometry pathogen identification and phenotypic antimicrobial susceptibility testing delivering MICs in hours, directly from clinical positive blood cultures - ECCMID 2018
2018
White Paper
The Importance of Controlled Inoculum
2024
Poster
Performance of a rapid phenotypic AST System for susceptibility testing of Gram-negative bacteraemia directly from positive blood culture bottles - ECCMID 2022.
2022
Poster
Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing - ECCMID 2022
2022
Poster
Rapid phenotypic AST System performance for Gram-negative bacteraemia susceptibility testing directly from positive blood culture bottles - ASM 2022
2022
Publication
Performance of a System for Rapid Phenotypic Antimicrobial Susceptibility Testing of Gram-Negative Bacteria Directly from Positive Blood Culture Bottles. Göransson, J et al.
2023
Publication
Rapid phenotypic antimicrobial susceptibility testing of Gram-negative rods directly from positive blood cultures using the novel Q-linea ASTar system. Esse, Jan et al.
2023
Publication
Evaluation of an automated rapid phenotypic antimicrobial susceptibility testing (ASTar, Q-linea AB) applied directly on blood cultures bottles positive for Gram-negative pathogens. Banchini, Isabella et al.
2024
Publication
Early detection of OXA-48 producing Klebsiella pneumoniae with the use of rapid antibiotic susceptibility testing. De Muynck, Emilie et al.
2025
Publication
Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective study. Messiaen, Anne-Sophie et al.
2025
Publication
An Evaluation of the ASTar Automated Antimicrobial Testing System for Gram-Negative Bacteria in Positive Blood Cultures. Coulson, Hannah et al.
2025
Poster
Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing - ASM 2022
2022
Presentations & webinars
RECORDED WEBINAR Cancer and AMR: A Roundtable Discussion
Originally broadcasted on November 21, 2025
Speakers:
Dr. Vikas Gupta PharmD, FIDSA
Sr Director, Q-linea, USA, and lead author of the two of featured publications
Dr. Michael Craig, MPP
Director, CDC Antimicrobial Resistance Coordination and Strategy Unit
Dr. Michael Satlin, MD, MS
Clinical Director, Transplantation, Oncology Infectious Disease Program at Weill Cornell Medicine
Dr. Yehoda Martel, MD, MSCE
Asst. Professor of Medicine and Vice Chief for Global Oncology, University of Pennsylvania
Recorded presentation from a workshop held at the AMCLI Congress, March 2024 Clinical Impact of rapid antimicrobial susceptibility testing on positive blood cultures from 200 patients with bacteremia: A prospective trial (English subtitles) Prof. Alexia Verroken, MD, PhD
Recorded presentation from a workshop held at the AMCLI Congress, March 2024 LIFETIMES – Risultati preliminari di uno studio multcentrico di Health Economics (English subtitles) Prof. Maurizio Sanguinetti
Universitá Cattolica del Sacro Cuore, Rome, Italy.
